Dextrose and Sodium Chloride NDC 63323-867

NDC codes

FDA NDC Directory

Product NDC (as listed)63323-867Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63323-0867Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
63323-867-10	63323086710	10 BAG in 1 CASE (63323-867-10) / 1000 mL in 1 BAGMarketed from Oct 26, 2020
63323-867-74	63323086774	20 BAG in 1 CASE (63323-867-74) / 500 mL in 1 BAGMarketed from Oct 26, 2020
63323-867-75	63323086775	30 BAG in 1 CASE (63323-867-75) / 250 mL in 1 BAGMarketed from Oct 26, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dextrose and Sodium Chloride
Generic name (nonproprietary): dextrose monohydrate and sodium chloride
Active ingredients: Dextrose monohydrate — 5 g/100mLSodium chloride — .3 g/100mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Fresenius Kabi USA, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211194
Marketing start: Oct 26, 2020
Listing expires: Dec 31, 2027
Other FDA classes: Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Osmotic Activity (Mechanism)
Identifiers: Product ID 63323-867_ee6bbc93-9dcb-4d7f-afe3-4588b0566d15SPL ID ee6bbc93-9dcb-4d7f-afe3-4588b0566d15SPL set ID 99c6a1a9-cadf-435b-a332-ccc189afdfa9RxCUI 1795147, 1795149, 1795150UNII LX22YL083G, 451W47IQ8X
Pharmacologic class: Osmotic Laxative

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N463323086710 followed by a unit qualifier and the quantity

Package 63323-0867-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 16, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Intravenous solutions containing dextrose and sodium chloride are indicated for parenteral replenishment of fluid, minimal carbohydrate calories, and sodium chloride as required by the clinical condition of the patient.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)